March 31, 2023
January 25, 2025
This week’s newsletter included:
-
Utah’s Life Sciences Industry Is #1 in Growth from 2012–2021
-
BioUtah Takes Part in BIO and AdvaMed Fly-Ins, Signs Letter to Congress to Eliminate Amortization of R&D Expenses
-
BioUtah Honors Mike Alder on His Retirement
-
MDMA 2023 Annual Meeting
-
Known Medicine Is Using Machine Learning to Cure Cancer
-
Lab Space Available – Slopes Bio
-
100 Companies Championing Women Nomination Application
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize